SCHEMBL19082974

SCHEMBL19082974

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5cccc(-c6cccc7c6oc6ccccc67)c54)c3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
PRKDC P78527 4/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CB P42338 1/20 0.38
MAPT P10636 4/20 0.36
TSHR P16473 2/20 0.36
GGPS1 O95749 1/20 0.35
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18566080 0.98 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL21192236 0.93 ALOX5 (0.40) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL21192251 0.93 ALOX5 (0.40) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL22049192 0.93 ALOX5 (0.37) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL18566082 0.93 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL24216597 0.92 ALOX5 (0.37) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL26194276 0.92 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL16185791 0.91 ALOX5 (0.40) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL17990719 0.91 MAPT (0.37) ALOX5MAPTTSHRKDM4EALDH1A1
SCHEMBL18505468 0.91 MAPT (0.37) ALOX5MAPTTSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10483471-B2 Organic electroluminescent element, method for producing organic electroluminescent element, display, and lighting device Konica Minolta, Inc. (JP) 2019-11-19 US disclosed
EP-3200255-A2 ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY, AND LIGHTING DEVICE Konica Minolta, Inc. (JP) 2017-08-02 EP disclosed
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device MERCK PATENT GMBH (DE) 2017-07-06 US disclosed
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device MERCK PATENT GMBH (DE) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10483471-B2 Organic electroluminescent element, method for producing organic electroluminescent element, display, and lighting device ELOVL5, ELOVL1, LAGE3 ALOX5 120/4885PRKDC 4760/4885PIK3CD 4415/4885
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device ELOVL5, ELOVL1, LAGE3 ALOX5 120/4885PRKDC 4760/4885PIK3CD 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.